The efficacy and safety of sulforaphane as an adjuvant in the treatment of bipolar depressive disorder: Study protocol for a randomized, double-blinded, placebo-controlled, parallel-group clinical trial

BACKGROUND: Bipolar disorder (BD) is a chronic and disabling psychiatric disorder. The treatment of BD still remains a significant clinical challenge due to the complex nature of the disease. Nutraceutical therapy as adjunctive role is a promising therapy for BD. Sulforaphane (SFN), a broccoli extra...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Congchong, Chen, Xingyang, Lai, Jianbo, Xu, Yi, Hu, Shaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328924/
https://www.ncbi.nlm.nih.gov/pubmed/32590809
http://dx.doi.org/10.1097/MD.0000000000020981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328924/
https://www.ncbi.nlm.nih.gov/pubmed/32590809
http://dx.doi.org/10.1097/MD.0000000000020981

Ejemplares similares